A class-action lawsuit has been authorized to proceed against 16 pharmaceutical companies for their role in manufacturing, selling, marketing and distributing opioid drugs in Quebec.Posted: Apr 15, 2024 6:00 PM EDT | Last Updated: 11 minutes ago
That means there could be thousands of people in the province who could join the case, said Margo Siminovitch, with the Montreal-based firm Fishman Flanz Meland Paquin . Margo Siminovitch, with the Montreal-based firm Fishman Flanz Meland Paquin, is one of the lawyers pursuing the class-action lawsuit.
He was diagnosed with severe opioid use disorder — a condition where people use the drugs compulsively even if they want to stop.The plaintiff is demanding $30,000 in damages for each member of the class action and for each defendant to pay $25 million.More than 1 in 4 deaths among young people in Canada were opioid-related in 2021, study finds
A person may have needed the drug only three to five days after a surgery, but were prescribed enough to last two or three weeks, he said.